Skromne EE, Rivera OVM, Ordoñez BL, Ontaneda JD

Language: Spanish
References: 9
Page: 164-169
PDF size: 70.20 Kb.

ABSTRACT

Multiple sclerosis (MS) is a disease with an autoinmune pathophysiology. A new and promising treatment in this group of patients is the blood and marrow stem cells transplantation which is currently an experimental treatment with evident immuno-suppressant effects. It has not been demonstrated any effect on neurodegeneration and it is preferred to use this procedure as a non-conventional treatment of multiple sclerosis. Selection of patients should be strict, mainly in patients with moderate severity and an important inflammatory component. It is not a rescue treatment because its utility in progressive forms or advanced MS has not been demonstrated and the risk is high. This review includes an analysis of the current protocols and their results.

REFERENCES

1. Burt R, Burns W, Hess. Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplantation 1995; 16: 1-6.

2. McAllister LD, Beatty PG, Rose J. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 1997; 19: 395-7.

3. Meloni G, Capria S, Salvetti M, Cordone I, Mancini M, Mandelli F. Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia. Haematologica 1999; 84: 665-7.

4. Mandalfino P, Rice G, Smith A, Klein JL, Rystedt L, Ebers GC. Bone marrow transplantation in multiple sclerosis. J Neurol 2000; 247: 691-5.

5. Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249: 1088–97.

6. Openshaw H, Lund BT, Kashyap, et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring. Biol Blood Marrow Transplant 2000; 6: 563-75.

7. Sainz A, Carreras E, Berenguer J, Yagüe J, Martinez C. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 2001; 56: 1084-9.

8. Comi L, Kappos M, Clanet G, Ebers A, Fassas, et al. Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. J Neurology 2000; 247: 376-82.

9. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain 2004; 127: 996-1008.